share_log

Cybin | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(7.65%),Deep Track Biotechnology Master Fund, Ltd.(7.65%), etc.

SEC announcement ·  Mar 22 16:08
Summary by Moomoo AI
On March 14, 2024, a Schedule 13G filing was made with the United States Securities and Exchange Commission by Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin, indicating a significant ownership stake in Cybin Inc. The filing revealed that the reporting entities collectively hold 58,139,535 common shares of Cybin Inc., representing 7.65% of the company's class of securities. The shares are held with shared voting and dispositive power. The filing, made under Rule 13d-1(c), is not intended to effect a change in control of Cybin Inc. but is a standard disclosure for entities owning more than five percent of a class of a company's shares. The principal business office addresses for the reporting persons are located in Greenwich, CT, and George Town, Cayman Islands, with citizenships in Delaware, Cayman Islands, and the United States, respectively. The filing was certified by David Kroin, the Managing Member of the General Partner of the Investment Adviser for Deep Track Capital, LP, and Director of Deep Track Biotechnology Master Fund, Ltd.
On March 14, 2024, a Schedule 13G filing was made with the United States Securities and Exchange Commission by Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin, indicating a significant ownership stake in Cybin Inc. The filing revealed that the reporting entities collectively hold 58,139,535 common shares of Cybin Inc., representing 7.65% of the company's class of securities. The shares are held with shared voting and dispositive power. The filing, made under Rule 13d-1(c), is not intended to effect a change in control of Cybin Inc. but is a standard disclosure for entities owning more than five percent of a class of a company's shares. The principal business office addresses for the reporting persons are located in Greenwich, CT, and George Town, Cayman Islands, with citizenships in Delaware, Cayman Islands, and the United States, respectively. The filing was certified by David Kroin, the Managing Member of the General Partner of the Investment Adviser for Deep Track Capital, LP, and Director of Deep Track Biotechnology Master Fund, Ltd.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more